Tissue Microarray (TMA) Technology: Principles and Typical Applications in Tumor Pathology Research

Basic Concepts and Preparation Workflow of Tissue Microarrays (TMAs)

A tissue microarray (TMA) is a high-throughput tissue analysis technique in which a large number of donor tissue samples are arranged in a predefined array within a single recipient paraffin block. Under common specifications, one recipient paraffin block can accommodate dozens to hundreds of tissue cores with diameters ranging from 0.6 mm to 2.0 mm. The specific core diameter and array density should be selected according to the research objective and tissue type.

The preparation workflow typically includes donor paraffin block screening and marking, target region localization, tissue core sampling, recipient paraffin block punching and implantation, and array block sectioning. Donor tissues are generally derived from formalin-fixed paraffin-embedded (FFPE) samples. Before sampling, a pathology professional must review the HE sections and mark representative tumor regions or specific lesion areas.

Core Advantages and Application Boundaries of Tissue Microarrays (TMAs)

Compared with conventional whole-tissue sections, tissue microarrays (TMAs) enable immunohistochemistry, in situ hybridization, or in situ fluorescence detection of multiple samples under the same experimental conditions, reducing batch-to-batch variation and conserving antibodies and reagents. They offer a clear efficiency advantage in initial screening of tumor markers, tissue-specific expression analysis, and antibody performance validation.

It should be noted that due to the limited area of a single tissue core, tissue microarrays (TMAs) are more suitable for studying expression trends at the population level and should not be used alone to replace morphological diagnosis on complete tissue sections. For tumors with strong heterogeneity, it is recommended to validate results in combination with complete sections from donor paraffin blocks.

Typical Applications of Tissue Microarrays (TMAs) in Tumor Research and Pathology Quality Control

Tumor marker screening: Tissue microarrays containing multiple cancer types or multiple stages are used to preliminarily evaluate the expression distribution and differences of candidate markers.

Antibody and probe validation: Different antibody clones or probes are simultaneously tested on tissue microarrays to compare staining specificity and background signal.

Inter-laboratory pathology quality control: The same tissue microarrays are distributed to different laboratories to evaluate immunohistochemical staining consistency and workflow stability.

With the development of biobanks and digital pathology technologies, tissue microarrays (TMAs) are gradually being combined with whole-slide scanning and image analysis, providing a standardized data source for multicenter retrospective studies.